Results 211 to 220 of about 54,453 (265)
Some of the next articles are maybe not open access.
Human medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Arthritis, Rheumatoid, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Arthritis, Rheumatoid, Date of authorisation: 01/10/2009, Revision: 33, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Hefiya, adalimumab, Hidradenitis Suppurativa,Spondylitis, Ankylosing,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Hefiya, adalimumab, Hidradenitis Suppurativa,Spondylitis, Ankylosing,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis, Date of authorisation: 26/07/2018, Revision: 3, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Enbrel, etanercept, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 02/02/2000, Revision: 58, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Enbrel, etanercept, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 02/02/2000, Revision: 59, Status: Authorised
Case Medical Research, 2019 openaire +1 more source